01
Low NADAC$34.84
→
Avg plan cost$34.84
Part D spend $38.0M
1× spread, current vs floor
Class summary at a glance.
Every drug in the Ergotamine Derivative class tracked across NADAC, Part D Formulary, Part D Spending, FDA Orange Book, and shortage data. Ranked below by CY24 Part D spend. Click any molecule for the full drug profile.
- Molecules in class
- 1tracked in Part D
- CY24 Part D spend
- $38.0Mcombined across class
- Total Rx claims
- 27K6K unique beneficiaries
- Generic mfrs (active)
- 9across all molecules